178 related articles for article (PubMed ID: 34880052)
21. Survival from uveal melanoma in Western Australia 1981-2005.
Chew AL; Spilsbury K; Isaacs TW
Clin Exp Ophthalmol; 2015 Jul; 43(5):422-8. PubMed ID: 25556534
[TBL] [Abstract][Full Text] [Related]
22. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Factors Five Years After Enucleation for Uveal Melanoma.
Dogrusöz M; Brouwer NJ; de Geus SJR; Ly LV; Böhringer S; van Duinen SG; Kroes WGM; van der Velden PA; Haasnoot GW; Marinkovic M; Luyten GPM; Kivelä TT; Jager MJ
Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):31. PubMed ID: 32186672
[TBL] [Abstract][Full Text] [Related]
24. Beta-blockers exert potent anti-tumor effects in cutaneous and uveal melanoma.
Bustamante P; Miyamoto D; Goyeneche A; de Alba Graue PG; Jin E; Tsering T; Dias AB; Burnier MN; Burnier JV
Cancer Med; 2019 Dec; 8(17):7265-7277. PubMed ID: 31588689
[TBL] [Abstract][Full Text] [Related]
25. Uveal Melanoma Metastasis to the Contralateral Eye Structures: A Retrospective Comparative Analysis of 13 Consecutive Patients.
Masoomian B; Mashayekhi A; Shields JA; Shields CL
Ophthalmol Retina; 2021 Oct; 5(10):1036-1042. PubMed ID: 33421627
[TBL] [Abstract][Full Text] [Related]
26. Immunomagnetic isolation and in vitro expansion of human uveal melanoma cell lines.
Cools-Lartigue JJ; McCauley CS; Marshall JC; Di Cesare S; Gregoire F; Antecka E; Logan P; Burnier MN
Mol Vis; 2008 Jan; 14():50-5. PubMed ID: 18246031
[TBL] [Abstract][Full Text] [Related]
27. Posterior uveal melanoma incidence and survival by AJCC tumour size in a 70-year nationwide cohort.
Smidt-Nielsen I; Bagger M; Heegaard S; Andersen KK; Kiilgaard JF
Acta Ophthalmol; 2021 Dec; 99(8):e1474-e1482. PubMed ID: 33738986
[TBL] [Abstract][Full Text] [Related]
28. Integrated differential DNA methylation and gene expression of formalin-fixed paraffin-embedded uveal melanoma specimens identifies genes associated with early metastasis and poor prognosis.
Ness C; Katta K; Garred Ø; Kumar T; Olstad OK; Petrovski G; Moe MC; Noer A
Exp Eye Res; 2021 Feb; 203():108426. PubMed ID: 33387485
[TBL] [Abstract][Full Text] [Related]
29. [Pathological and molecular genetic characteristics in patients with extrabulbar growth of uveal melanoma].
Saakyan SV; Khoroshilova-Maslova IP; Tsygankov АY; Amiryan АG; Isaeva RТ
Arkh Patol; 2016; 78(4):20-26. PubMed ID: 27600778
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression analysis and Multiplex ligation-dependent probe amplification in metastatic and non-metastatic uveal melanoma.
Larsen AC; Holst L; Kaczkowski B; Andersen MT; Manfé V; Siersma VD; Kolko M; Kiilgaard JF; Winther O; Prause JU; Gniadecki R; Heegaard S
Acta Ophthalmol; 2014 Sep; 92(6):541-9. PubMed ID: 24373459
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.
Harda K; Szabo Z; Szabo E; Olah G; Fodor K; Szasz C; Mehes G; Schally AV; Halmos G
Molecules; 2018 Jun; 23(7):. PubMed ID: 29949880
[TBL] [Abstract][Full Text] [Related]
33. Liver metastasis in uveal melanoma - treatment options and clinical outcome.
Kaštelan S; Mrazovac Zimak D; Ivanković M; Marković I; Gverović Antunica A
Front Biosci (Landmark Ed); 2022 Feb; 27(2):72. PubMed ID: 35227015
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of legumain in uveal melanoma.
Wu T; Sun L; Wu Y; Xiang R; Li Y; Rong W; Sun F; Wang N
Mol Med Rep; 2016 Mar; 13(3):2377-84. PubMed ID: 26846877
[TBL] [Abstract][Full Text] [Related]
35. Worldwide Incidence of Ocular Melanoma and Correlation With Pigmentation-Related Risk Factors.
Wu M; Yavuzyigitoglu S; Brosens E; Ramdas WD; Kiliç E;
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):45. PubMed ID: 37902747
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
Kashyap S; Singh MK; Jha J; Singh L; Pushker N; Sen S; Venkatesh P; Meel R; Lomi N
Hum Cell; 2020 Oct; 33(4):1264-1272. PubMed ID: 32686068
[TBL] [Abstract][Full Text] [Related]
37. Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysis.
Delgado-Ramos GM; Thomas F; VanderWalde A; King B; Wilson M; Pallera AM
Med Oncol; 2019 Jan; 36(2):17. PubMed ID: 30666496
[TBL] [Abstract][Full Text] [Related]
38. The incidence of childhood cancer in Australia, 1983-2015, and projections to 2035.
Youlden DR; Baade PD; Green AC; Valery PC; Moore AS; Aitken JF
Med J Aust; 2020 Feb; 212(3):113-120. PubMed ID: 31876953
[TBL] [Abstract][Full Text] [Related]
39. Current molecular and clinical insights into uveal melanoma (Review).
Fallico M; Raciti G; Longo A; Reibaldi M; Bonfiglio V; Russo A; Caltabiano R; Gattuso G; Falzone L; Avitabile T
Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649778
[TBL] [Abstract][Full Text] [Related]
40. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
